
Fluid overload is associated with worse outcomes in critically ill patients requiring continuous renal replacement therapy (CRRT). Net ultrafiltration (UFNET) allows precise control of the fluid removal but is frequently ceased due to hemodynamic instability episodes. The study presents in the current protocol all study procedures regarding the achievement of the GO NEUTRAL trial to prevent biased analysis of trial outcomes and improve the transparency of the trial result report. Enrollment of patients in the GO NEUTRAL trial started on June 31, 2021, and is ongoing.
Like
Save
Share